ClinicalTrials.Veeva

Menu

Structural and Molecular Neuroplasticity in Migraine

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Migraine

Treatments

Procedure: Pet Scan
Procedure: MRI scan
Procedure: Quantitative Sensory Testing (QST)

Study type

Interventional

Funder types

Other

Identifiers

NCT03004313
HUM00027383

Details and patient eligibility

About

The main purpose of this study is to integrate novel MRI techniques with positron emission tomography(PET) for the study of structural and molecular neuroplasticity in the brain of migraineurs, and its clinical association with changes in pain perception and modulation (e.g. allodynia). We will attempt to acquire images of the brain that may, in the future, assist doctors in better understanding how pain is felt and regulated in migraine sufferers.

Full description

To investigate interictal opioid receptor (MOR) binding potential (BPND) changes in migraineurs as compared to age/gender-matched healthy controls. To demonstrate that frequency of the headache attacks and severity of cutaneous allodynia levels in migraineurs experienced over multiple attacks are correlated with levels of MOR BPND in specific brain regions. To investigate whether dysfunction of the pain regulatory endogenous opioid system of migraineurs is correlated with changes in the gray matter thickness in cortical areas associated with pain perception and modulation.

Enrollment

32 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between 18-45 years of age
  • Between 1-14 migraine attacks per month or healthy

Exclusion criteria

  • Cannot be taking daily migraine medication
  • Healthy subjects cannot be taking hormonal birth control pills or other medication
  • Cannot have chronic pain or a neurologic/psychiatric disorder such as: multiple sclerosis and bipolar disorder.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups

Migraine
Experimental group
Description:
20 subjects experiencing 1-14 migraines per month will undergo the following: * Blood and urine samples will be collected * Complete a series of questionnaires; some of which will be completed daily * Quantitative Sensory Test (QST)will be performed * Magnetic Resonance Imaging (MRI) * PET imaging (during and outside of a migraine attack)
Treatment:
Procedure: MRI scan
Procedure: Pet Scan
Procedure: Quantitative Sensory Testing (QST)
Healthy
Active Comparator group
Description:
20 healthy subjects will undergo the following: * Blood and urine samples will be collected * Complete a series of questionnaires; some of which will be completed daily * Quantitative Sensory Test (QST)will be performed * Magnetic Resonance Imaging (MRI) * PET imaging
Treatment:
Procedure: MRI scan
Procedure: Pet Scan
Procedure: Quantitative Sensory Testing (QST)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems